Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000146780 | SCV000194105 | likely benign | not specified | 2013-02-08 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000146780 | SCV000314051 | likely benign | not specified | criteria provided, single submitter | clinical testing | ||
Labcorp Genetics |
RCV001618298 | SCV000749483 | benign | not provided | 2025-01-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002312968 | SCV000847370 | benign | Inborn genetic diseases | 2016-08-03 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001618298 | SCV001844305 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003231185 | SCV002054852 | benign | Sotos syndrome | 2021-07-15 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV003231185 | SCV002802782 | benign | Sotos syndrome | 2021-09-27 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV003231185 | SCV004564814 | benign | Sotos syndrome | 2023-09-18 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001618298 | SCV005222545 | likely benign | not provided | criteria provided, single submitter | not provided |